Skip to main content
SRZN
NASDAQ Life Sciences

10% Owner TCG Crossover Funds Increase Stake in Surrozen with $1.22M Open Market Purchase

Analysis by Wiseek AI
Sentiment info
Positive
Importance info
7
Price
$25.5
Mkt Cap
$218.571M
52W Low
$5.9
52W High
$29.595
Market data snapshot near publication time

Summary

TCG Crossover Fund II, L.P. and TCG Crossover Fund III, L.P., along with their general partners, collectively increased their holdings in Surrozen, Inc. through open market purchases totaling over $1.22 million.


Key Events

  • Significant Insider Purchase

    TCG Crossover Fund II, L.P. and TCG Crossover Fund III, L.P., both 10% owners, collectively purchased 48,997 shares of Surrozen, Inc. common stock.

  • Substantial Investment

    The open market purchases totaled $1,220,362, executed across six transactions between March 12 and March 16, 2026, at prices ranging from $24.88 to $24.99 per share.

  • Continued Accumulation

    This transaction adds to a pattern of insider accumulation, with net insider buys totaling $647,379 in the 90 days prior to this filing, indicating ongoing investor confidence.


Analysis

This Form 4 filing indicates a significant vote of confidence from a major institutional investor. TCG Crossover Funds, identified as 10% owners, acquired over $1.22 million worth of Surrozen common stock through multiple open market transactions between March 12 and March 16, 2026. While 10% owners are financial investors rather than operational insiders, such a substantial purchase suggests a positive outlook on the company's prospects and could be interpreted as a bullish signal for other investors. This purchase contributes to a broader pattern of insider accumulation observed over the last 90 days.

At the time of this filing, SRZN was trading at $25.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $218.6M. The 52-week trading range was $5.90 to $29.60. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SRZN - Latest Insights

SRZN
May 18, 2026, 6:49 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $28.15
Real-time Price: $23.39 info
Change: -$4.76 (-17%) info
Market Cap: $271.567M info
SRZN
May 06, 2026, 4:49 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $34.13
Real-time Price: $23.39 info
Change: -$10.74 (-31%) info
Market Cap: $271.567M info
SRZN
May 06, 2026, 4:38 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $34.13
Real-time Price: $23.39 info
Change: -$10.74 (-31%) info
Market Cap: $271.567M info
SRZN
Mar 30, 2026, 6:21 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $27.45
Real-time Price: $23.39 info
Change: -$4.06 (-15%) info
Market Cap: $271.567M info
SRZN
Mar 25, 2026, 8:02 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $26.14
Real-time Price: $23.39 info
Change: -$2.75 (-11%) info
Market Cap: $271.567M info
SRZN
Mar 23, 2026, 5:26 PM EDT
Filing Type: S-3
Importance Score:
9
Price at Filing: $25.24
Real-time Price: $23.39 info
Change: -$1.85 (-7%) info
Market Cap: $271.567M info
SRZN
Mar 23, 2026, 4:30 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $25.24
Real-time Price: $23.39 info
Change: -$1.85 (-7%) info
Market Cap: $271.567M info
SRZN
Mar 23, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $25.24
Real-time Price: $23.39 info
Change: -$1.85 (-7%) info
Market Cap: $271.567M info
SRZN
Mar 23, 2026, 4:05 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $25.24
Real-time Price: $23.39 info
Change: -$1.85 (-7%) info
Market Cap: $271.567M info
SRZN
Mar 16, 2026, 7:05 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $25.50
Real-time Price: $23.39 info
Change: -$2.11 (-8%) info
Market Cap: $271.567M info